Related Experiment Video
Updated: Sep 21, 2026

Detection of Low Copy Number Integrated Viral DNA Formed by In Vitro Hepatitis B Infection
Published on: November 7, 2018
Chronic hepatitis virus infection in children
1Department of Pediatrics, College of Medicine, National Taiwan University, Taipei. mhchang@ha.mc.ntu.edu.tw
Insights
Hepatitis B and C viruses cause chronic liver disease in children, with transmission occurring perinatally or horizontally. Universal HBV immunization significantly reduced carrier rates, but HCV prevention requires further vaccine development.
Area of Science:
- Pediatrics
- Hepatology
- Infectious Diseases
Background:
- Hepatitis B virus (HBV) and Hepatitis C virus (HCV) are primary causes of chronic liver disease in children.
- HBV transmission occurs perinatally from HBeAg-positive mothers or horizontally via contaminated needles and intrafamilial spread.
- HCV infection in children is linked to blood product exposure, maternal infection, and unsterile needles in endemic areas.
Purpose of the Study:
- To review the epidemiology, transmission, and management of HBV and HCV infections in pediatric populations.
- To highlight the impact of immunization programs and current challenges in preventing viral hepatitis in children.
Main Methods:
- Review of existing literature on pediatric HBV and HCV infections.
- Analysis of transmission routes, natural history, and clinical outcomes.
- Evaluation of the effectiveness of current prevention strategies.
Main Results:
- Universal HBV immunization has drastically reduced carrier rates and hepatocellular carcinoma incidence in children.
- Spontaneous HBeAg/anti-HBe seroconversion in HBV infection is rare in young children, increasing with age.
- Mother-to-infant HCV transmission occurs in about 5% of cases, influenced by maternal viral load; genotype Ib is most common.
- Chronicity develops in 60-80% of pediatric HCV cases, often with minimal liver histology changes.
Conclusions:
- While HBV immunization is highly effective, ongoing vigilance and research are needed for HCV prevention, particularly for mother-to-infant transmission.
- Vaccine development for HCV is crucial to reduce pediatric infections and long-term liver disease.
- Screening of blood products has reduced HCV transmission, but other routes require continued attention.
Abstract:
Hepatitis B and C viruses (HBV and HCV) are the two main hepatitis viruses causing chronic liver diseases in children. In hyperendemic areas, nearly half of the primary infection in chronic HBV carriers occurs during the perinatal period through the transmission from hepatitis B e antigen (HBeAg)-positive mothers. The other half are from horizontal transmission mainly through intrafamilial spread or injection using unsterilized needles. During the natural course of chronic HBV infection, spontaneous HBeAg/anti-HBe seroconversion occurs very rarely (2% annually) before 3 years of age. After 3 years of age, the HBeAg seroconversion rate increases gradually to 5% per year. Those with mothers who are hepatitis B carriers tend to clear HBeAg slower than those whose mothers are non-carriers. Transplacental HBeAg may cause T cell tolerance in infected children. Universal HBV immunization programmes have been effective in reducing the hepatitis B carrier rate more than 10-fold, and the incidence of hepatocellular carcinoma in children has also been decreased significantly. Hepatitis C virus infection occurs mainly in high-risk children, such as those who received blood products (blood diseases, malignancies, post-open heart surgery etc.), children of HCV-infected mothers, and in hyperendemic areas, from injection using unsterile needles. Mother-to-infant transmission occurs on average in 5% of infants of viraemic mothers. The maternal HCV-RNA titre is the most important factor determining the infectivity. Chronicity developed in 60-80% of HCV-infected children. Although transient or persistent elevation of aminotransferases occurs frequently in chronically HCV-infected children, liver histology showed minimal or mild changes only. The most prevalent genotype of HCV in children is Ib. Screening of the blood products for HCV antibody has markedly reduced the rate of HCV infection in children at risk. However, vaccine development is needed to prevent mother-to-infant transmission and other routes of infections.
Related Concept Videos
Chickenpox
Poliomyelitis
Cytomegalovirus Disease
Hepatitis
Viral Hepatitis I: Introduction
Chronic Pancreatitis I: Introduction

